Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit

Safety of Gadolinium-Based Contrast Agents: A Four Part Webcast Series

A review of the literature indicates an increased incidence of gadolinium deposition in the brain as a result of repeated contrast-enhanced MR imaging procedures. With a wide selection of gadolinium-based contrast agents available; imaging professionals must be aware of their chemical make-up when selecting the best agent for a particular study.

In this updated 4-Part webcast series, chaired by Lawrence N. Tanenbaum, MD FACR and featuring an esteemed faculty, which includes Dr. Kenneth Maravilla, Dr. Donna Roberts, Dr. Richard Semelka and Dr. Lawrence Tanenbaum; we review the current role of gadolinium-based contrast media in adult and pediatric patients through didactic presentation and roundtable discussion. In light of recent discoveries, faculty will review the characteristics of a gadolinium-based agent when making choices in patients with both normal and abnormal renal function.

These activities have been supported through an unrestricted educational grant from Guerbet, LLC.

Part 1: Safety of Gadolinium-Based Contrast Agents: Structure, Stability, NSF & Tissue Deposition
Original Program Date: May 17, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this first (1) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Kenneth Maravilla reviews the safety profiles of the currently available agents, identifies the risk factors for NSF and discusses the current understanding and outstanding issues related to Gadolinium deposition in the brain and other tissues in patients with normal renal function.
Following Dr. Maravilla's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Part 2: Gadolinium Based Contrast Agents and Pediatric Long Term Safety
Original Program Date: June 14, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this second (2) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Donna Roberts will discuss clinical indications for post contrast MR imaging, review the current literature as it relates to gadolinium retention and discuss considerations for selecting a GBCA when imaging pediatric patients.
Following Dr. Roberts presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Part 3: Contrast Enhanced Body MR Imaging: Making Diagnoses While Managing Risks
Original Program Date: June 12, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this third (3) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Richard Semelka shares his clinical experiences and best practices as it relates to the use of Gadolinium Based Contrast Agents (GBCAs) in body MR imaging.
Following Dr. Semelka's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Part 4: Contrast Enhanced Neuro MRI: New Issues, New Indications
Original Program Date: August 18, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this final CME/CE Accredited Expert Forum Webcast of our four-part series, Dr. Lawrence Tanenbaum reviews contrast-enhanced Neuro MRI with an emphasis on current practices and indications as well as a survey of manifestations of diseases on contrast-enhanced MRI of the brain and spine.
Following Dr. Tanenbaum's presentation, questions from the audience are addressed.
To View The On-Demand Program and Claim Credit Select Profession

Contrast Enhancement in MR Imaging: A Four Part Webcast Series

New Options, New Techniques, New Opportunities

As options in available gadolinium-based contrast agents expand, clinicians have more choices than ever when choosing an agent. In this 4-Part Expert Forum Series, produced by the Institute for Advanced Medical Education and hosted by Applied Radiology, The Journal for Practical Medical Imaging & Management, we will call on the clinical experience and expertise of four well-respected physicians who will discuss the effective, safe and sometimes, innovative use of MR contrast in Body, Pediatric and Neuro MR applications.

These activities have been supported through an unrestricted educational grant from Guerbet, LLC.

Nephrogenic Systemic Fibrosis (NSF) Update, 2014: Fact Versus Theory
Original Program Date: July  17, 2014     Format: Audio Visual     Approx. Run Time: 60 Minutes    
In this first of a four (4) part educational webcast series we will hear from Dr. Emanuel Kanal from the University of Pittsburgh Medical Center who will share his experience and knowledge on MR Safety as it relates Nephrogenic Systemic Fibrosis (NSF) in Gadolinium Based Contrast Agents (GCBAs).
In this lecture, Dr. Kanal will also review the available gadolinium based contrast agents (GCBAs), their chemical properties and discuss how their design can impact their clinical utility and safety in various clinical applications.
Following Dr. Kanal's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program Select Profession (Credit No Longer Available, View Only)
Utilization of MRI-Based Contrast Agents In The Pediatric Patient
Original Program Date: Sept. 16, 2014     Credits: 1     Format: Audio Visual     Approx. Run Time: 60 Minutes     Fee: No Charge
In this second of a four (4) part educational webcast series we hear from Dr. Alexander Towbin from Cincinnati Children's Hospital, who discusses the use of MR contrast agents in routine pediatric imaging of the chest, abdomen, and pelvis. In addition, Dr. Towbin addresses the pros and cons of various MR contrast agents and shows examples of their use in clinical practice.
Following Dr. Tobin's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Utilization of MR Contrast in Body Imaging Applications
Original Program Date: October 23, 2014    Credits: 1    Format: Audio Visual    Approx. Run Time: 60 Minutes    Fee: No Charge
In this third of a four (4) part educational webcast series, we hear from Dr. Richard Semelka from the University of North Carolina who shares his clinical experience using a variety of MR contrast agents in body imaging applications. In addition, he reviews the results of a double-blinded study that evaluated the use of various agents and shares his thoughts on the results.
Following Dr. Semelka's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Contrast Enhanced Neuro MRI: Issues and Indications
Original Program Date: Nov. 18, 2014    Credits: 1    Format: Audio Visual    Approx. Run Time: 60 Minutes    Fee: No Charge
In this last of a four (4) part educational webcast series we hear from Dr. Lawrence N. Tanenbaum from Mount Sinai Hospital, who provides a survey of contrast enhanced neuro MRI with an emphasis on current practices and indications as well as a survey of manifestations of diseases on contrast enhanced MRI of the brain and spine.
Following his lecture, Dr. Tanenbaum participates in moderated discussion by Applied Radiology where questions from the audience are addressed.
To View The On-Demand Program and Claim Credit Select Profession